NO976064D0 - Somatostatin peptider - Google Patents

Somatostatin peptider

Info

Publication number: NO976064D0
Authority: NO; Norway
Prior art keywords: residue; ala; amino acid; lys; somatostain
Prior art date: 1995-06-29

Application number

NO976064A

Other languages

English (en)

Other versions

NO317867B1 (no

NO976064L (no

Inventor

Rainer Albert

Wilfried Bauer

Christian Bruns

Nagarajan Chandramouli

Ian Lewis

Gisbert Weckbecker

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-29

Filing date

1997-12-23

Publication date

1997-12-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26307298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO976064(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-06-29 Priority claimed from GBGB9513224.7A external-priority patent/GB9513224D0/en

1996-01-10 Priority claimed from GBGB9600429.6A external-priority patent/GB9600429D0/en

1997-12-23 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1997-12-23 Publication of NO976064D0 publication Critical patent/NO976064D0/no

1998-02-16 Publication of NO976064L publication Critical patent/NO976064L/no

2004-12-27 Publication of NO317867B1 publication Critical patent/NO317867B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Obesity (AREA)
Hematology (AREA)

NO19976064A 1995-06-29 1997-12-23 Sykliske somatostatin heksapeptider, farmasoytiske sammensetninger omfattende slike, og anvendelse av slike heksapeptider for fremstilling av farmasoytiske sammensetninger. NO317867B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9513224.7A GB9513224D0 (en)	1995-06-29	1995-06-29	Organic compounds
GBGB9600429.6A GB9600429D0 (en)	1996-01-10	1996-01-10	Organic compounds
PCT/EP1996/002840 WO1997001579A2 (en)	1995-06-29	1996-06-28	Somatostatin peptides

Publications (3)

Publication Number	Publication Date
NO976064D0 true NO976064D0 (no)	1997-12-23
NO976064L NO976064L (no)	1998-02-16
NO317867B1 NO317867B1 (no)	2004-12-27

Family

ID=26307298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19976064A NO317867B1 (no)	1995-06-29	1997-12-23	Sykliske somatostatin heksapeptider, farmasoytiske sammensetninger omfattende slike, og anvendelse av slike heksapeptider for fremstilling av farmasoytiske sammensetninger.

Country Status (24)

Country	Link
US (1)	US6225284B1 (no)
EP (1)	EP0835263B9 (no)
JP (2)	JP3445796B2 (no)
KR (1)	KR100454664B1 (no)
CN (1)	CN1156492C (no)
AT (1)	ATE210152T1 (no)
AU (1)	AU714447B2 (no)
BR (1)	BR9609335B8 (no)
CA (1)	CA2222524C (no)
CZ (1)	CZ297381B6 (no)
DE (1)	DE69617687T2 (no)
DK (1)	DK0835263T3 (no)
ES (1)	ES2169251T3 (no)
HU (1)	HU228984B1 (no)
IL (1)	IL122243A (no)
MY (1)	MY147327A (no)
NO (1)	NO317867B1 (no)
NZ (1)	NZ313147A (no)
PL (1)	PL184947B1 (no)
PT (1)	PT835263E (no)
SK (1)	SK284087B6 (no)
TR (1)	TR199701718T1 (no)
TW (1)	TW491854B (no)
WO (1)	WO1997001579A2 (no)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7238340B1 (en) *	1991-11-27	2007-07-03	Cis Bio International	Monoamine, diamide, thiol-containing metal chelating agents
JPH10251296A (ja) *	1997-03-06	1998-09-22	American Cyanamid Co	ソマトスタチン拮抗薬として有用なペプチド
US6004928A (en) *	1997-05-13	1999-12-21	Biomeasure, Incorporated	Method of treating hyperlipidemia
EP0981363B1 (en)	1997-05-13	2003-07-30	Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.)	Somatostatin agonists for decreasing body weight
US7026289B2 (en)	1997-05-13	2006-04-11	Societe De Conseils De Recherches Et D'applications Scientifiques, Sas	Method and compositions for treating hyperlipidemia and other conditions
US5968903A (en) *	1998-05-07	1999-10-19	Biomeasure, Incorporated	Inhibition of H. pylori proliferation
SE9802080D0 (sv) *	1998-06-11	1998-06-11	Hellstroem	Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
US6608027B1 (en)	1999-04-06	2003-08-19	Boehringer Ingelheim (Canada) Ltd	Macrocyclic peptides active against the hepatitis C virus
US6358491B1 (en)	1999-08-27	2002-03-19	Berlex Laboratories, Inc.	Somatostatin analogs
JP2003514867A (ja) *	1999-11-29	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ウロテンシン−ｉｉ環状類似物
GB0018891D0 (en)	2000-08-01	2000-09-20	Novartis Ag	Organic compounds
US7906103B2 (en)	2000-03-08	2011-03-15	Gerhard Graupner	Methods and compositions for targeted drug delivery
US7122172B1 (en)	2000-03-08	2006-10-17	Gerhart Graupner	Methods and compositions for targeted drug delivery
BR0210915A (pt)	2001-06-08	2004-06-08	Sod Conseils Rech Applic	Análogos quiméricos de somatostatina-dopamina
US7189856B2 (en) *	2001-12-28	2007-03-13	Gideon Shapiro	Non-peptide somatostatin receptor ligands
US7635463B2 (en) *	2002-02-27	2009-12-22	Pharmain Corporation	Compositions for delivery of therapeutics and other materials
US20050260259A1 (en) *	2004-04-23	2005-11-24	Bolotin Elijah M	Compositions for treatment with glucagon-like peptide, and methods of making and using the same
DE60335608D1 (de) *	2002-02-27	2011-02-17	Pharmain Corp	Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
US7122622B2 (en)	2002-04-16	2006-10-17	Biosynthema Inc.	Peptide compounds having improved binding affinity to somatostatin receptors
EP1358890A1 (en) *	2002-05-03	2003-11-05	BioSynthema, Inc	Benzothienyl analogue of somatostatine, selective for certain somatostatin receptors
PL215228B1 (pl) *	2002-05-20	2013-11-29	Bristol Myers Squibb Co	Zwiazki tripeptydowe, ich zastosowanie i kompozycja farmaceutyczna je zawierajaca oraz jej zastosowanie
PL213029B1 (pl)	2002-05-20	2012-12-31	Bristol Myers Squibb Co	Podstawiona pochodna cykloalkilowa, zawierajaca ja kompozycja oraz ich zastosowanie
MY140680A (en) *	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
PL211889B1 (pl)	2002-05-20	2012-07-31	Bristol Myers Squibb Co	Pochodna heterocyklosulfonamidowa, kompozycja ją zawierająca oraz ich zastosowanie
BR0316523A (pt) *	2002-11-25	2005-10-18	Attenuon Llc	Composto, composição farmacêutica e método para tratar ou prevenir câncer em um paciente
GB0229020D0 (en) *	2002-12-12	2003-01-15	Novartis Ag	Organic compounds
KR101018491B1 (ko)	2002-12-12	2011-03-03	노파르티스 아게	4-히드록시-프롤린 하부구조를 포함하는 펩티드의 합성 방법
GB0300095D0 (en) *	2003-01-03	2003-02-05	Novartis Ag	Organic compounds
RU2361876C2 (ru)	2003-04-22	2009-07-20	Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик С.А.С.	Пептидные векторы
AR044852A1 (es) *	2003-06-24	2005-10-05	Novartis Ag	Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina
ATE500264T1 (de)	2003-09-22	2011-03-15	Boehringer Ingelheim Int	Makrozyklische peptide mit wirkung gegen das hepatitis-c-virus
EP1522311A1 (fr)	2003-10-10	2005-04-13	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
US7132504B2 (en)	2003-11-12	2006-11-07	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
GB0326602D0 (en) *	2003-11-14	2003-12-17	Novartis Ag	Organic compounds
MY158342A (en)	2003-11-14	2016-09-30	Novartis Ag	Pharmaceutical composition
US7309708B2 (en)	2003-11-20	2007-12-18	Birstol-Myers Squibb Company	Hepatitis C virus inhibitors
US7135462B2 (en)	2003-11-20	2006-11-14	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
ES2358333T3 (es)	2004-01-21	2011-05-09	Boehringer Ingelheim International Gmbh	Péptidos macrocíclicos con acción contra el virus de la hepatitis c.
GB0428151D0 (en)	2004-12-22	2005-01-26	Novartis Ag	Organic compounds
WO2006114324A1 (en) *	2005-04-28	2006-11-02	Schering Ag	Compounds comprising cyclized somatostatin receptor binding peptides
EP1717247A1 (en) *	2005-04-28	2006-11-02	Schering AG	Cyclic peptides binding to the somatostatin receptor
EP1941902A1 (en) *	2007-01-02	2008-07-09	Novartis AG	Use of Somatostatin analogs in cluster headache
UA98494C2 (uk) *	2007-06-29	2012-05-25	Гіліад Сайєнсіз, Інк.	Противірусні сполуки
BRPI0813733A2 (pt)	2007-06-29	2019-11-05	Gilead Sciences Inc	composto com atividade inibidora de hcv, sua composição farmacêutica e seu uso.
US20100273719A1 (en)	2007-11-28	2010-10-28	Novartis Ag	Use of somatostatin analogs in meningioma
US8937152B2 (en) *	2007-12-03	2015-01-20	Italfarmaco Spa	Non-selective somatostatin analogues
EP2067786A1 (en)	2007-12-07	2009-06-10	ITALFARMACO S.p.A.	Novel non selective analogs of somatostatin
US10240138B2 (en)	2008-06-12	2019-03-26	Ipsen Bioinnovation Limited	Polypeptides that bind to and inhibit secretion from growth hormone secreting cells
CN104328100B (zh)	2008-06-12	2019-08-23	益普生生物创新有限公司	神经内分泌病的抑制
PT2310042E (pt) *	2008-07-08	2013-03-11	Novartis Ag	Uso de pasireotido para o tratamento de hipoglicemia hiperinsulinémica endógena
EP2213307A1 (en)	2009-02-03	2010-08-04	Novartis AG	Injectable depot formulations
EP2172189A1 (en)	2008-10-01	2010-04-07	Novartis AG	Pharmaceutical Compositions
EP2168983A1 (fr)	2008-09-30	2010-03-31	Ipsen Pharma	Nouveaux composés octapeptidiques et leur utilisation thérapeutique
GB0820970D0 (en)	2008-11-17	2008-12-24	Syntaxin Ltd	Suppression of cancer
UY32325A (es) *	2008-12-19	2010-07-30	Gilead Sciences Inc	Inhibidores de ns3 proteasa del vhc
EP2380596A1 (en) *	2010-04-20	2011-10-26	Technische Universität München	Cyclopentapeptide derivatives and uses thereof
WO2016097962A1 (en)	2014-12-19	2016-06-23	Auro Peptides Ltd	A process for the preparation of pasireotide
CN106432429A (zh) *	2016-10-24	2017-02-22	合肥国肽生物科技有限公司	一种帕西瑞肽的合成方法
HRP20231458T1 (hr)	2017-01-12	2024-05-10	Radiomedix Inc.	Liječenje stanica raka koje prekomjerno eksprimiraju receptore za somatostatin primjenom derivata oktreotida keliranih sa radioizotopima
TWI888355B (zh)	2018-07-25	2025-07-01	法商高級催化劑應用品有限公司	穩定的、濃縮的放射性核種錯合物溶液
US10596278B2 (en)	2018-07-25	2020-03-24	Advanced Accelerator Applications (Italy) S.R.L.	Stable, concentrated radionuclide complex solutions
US10596276B2 (en)	2018-07-25	2020-03-24	Advanced Accelerator Applications (Italy) S.R.L.	Stable, concentrated radionuclide complex solutions
CN119708199A (zh) *	2023-09-27	2025-03-28	钱杭江医药科技(嘉兴)有限公司	生长抑素肽类类似物、螯合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3863008A (en) *	1973-06-11	1975-01-28	American Home Prod	Somatostatin as stimulant of luteinizing hormone secretion
NZ195303A (en) *	1979-10-31	1984-10-19	Merck & Co Inc	Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions
US4292972A (en) *	1980-07-09	1981-10-06	E. R. Squibb & Sons, Inc.	Lyophilized hydrocolloio foam
US4505897A (en) *	1983-04-18	1985-03-19	The Administrators Of The Tulane Educational Fund	Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
US4612366A (en)	1985-06-17	1986-09-16	Merck & Co., Inc.	Cyclic hexapeptide somatostatin analogs
CA2012115C (en)	1989-03-15	2001-07-03	Biomeasure, Inc.	Iodinated somatostatins
WO1990012811A1 (en) *	1989-04-26	1990-11-01	The Administrators Of The Tulane Educational Fund	Linear somatostatin analogs
US5716596A (en) *	1992-06-23	1998-02-10	Diatide, Inc.	Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
EP1099707A3 (en) *	1993-06-23	2002-01-09	Diatide, Inc.	Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses

1996
- 1996-06-27 MY MYPI96002639A patent/MY147327A/en unknown
- 1996-06-28 HU HU9901455A patent/HU228984B1/hu unknown
- 1996-06-28 DK DK96924811T patent/DK0835263T3/da active
- 1996-06-28 US US08/981,426 patent/US6225284B1/en not_active Expired - Lifetime
- 1996-06-28 WO PCT/EP1996/002840 patent/WO1997001579A2/en active IP Right Grant
- 1996-06-28 TR TR97/01718T patent/TR199701718T1/xx unknown
- 1996-06-28 CN CNB961951206A patent/CN1156492C/zh not_active Expired - Lifetime
- 1996-06-28 PT PT96924811T patent/PT835263E/pt unknown
- 1996-06-28 CA CA2222524A patent/CA2222524C/en not_active Expired - Lifetime
- 1996-06-28 EP EP96924811A patent/EP0835263B9/en not_active Expired - Lifetime
- 1996-06-28 AT AT96924811T patent/ATE210152T1/de active
- 1996-06-28 PL PL96323943A patent/PL184947B1/pl unknown
- 1996-06-28 ES ES96924811T patent/ES2169251T3/es not_active Expired - Lifetime
- 1996-06-28 DE DE69617687T patent/DE69617687T2/de not_active Expired - Lifetime
- 1996-06-28 KR KR1019970709796A patent/KR100454664B1/ko not_active Expired - Lifetime
- 1996-06-28 CZ CZ0419697A patent/CZ297381B6/cs not_active IP Right Cessation
- 1996-06-28 NZ NZ313147A patent/NZ313147A/xx not_active IP Right Cessation
- 1996-06-28 BR BRPI9609335-8B8A patent/BR9609335B8/pt not_active IP Right Cessation
- 1996-06-28 SK SK1770-97A patent/SK284087B6/sk not_active IP Right Cessation
- 1996-06-28 JP JP53683496A patent/JP3445796B2/ja not_active Expired - Lifetime
- 1996-06-28 IL IL12224396A patent/IL122243A/xx not_active IP Right Cessation
- 1996-06-28 AU AU65150/96A patent/AU714447B2/en not_active Expired
- 1996-08-06 TW TW085109489A patent/TW491854B/zh not_active IP Right Cessation
1997
- 1997-12-23 NO NO19976064A patent/NO317867B1/no not_active IP Right Cessation
2002
- 2002-07-17 JP JP2002208012A patent/JP2003104998A/ja active Pending

Also Published As

Publication number	Publication date
BR9609335B8 (pt)	2014-10-07
EP0835263A2 (en)	1998-04-15
IL122243A (en)	2005-09-25
WO1997001579A2 (en)	1997-01-16
ES2169251T3 (es)	2002-07-01
KR19990028480A (ko)	1999-04-15
WO1997001579A3 (en)	1997-02-27
US6225284B1 (en)	2001-05-01
DK0835263T3 (da)	2002-04-02
JP2003104998A (ja)	2003-04-09
CN1189166A (zh)	1998-07-29
TW491854B (en)	2002-06-21
IL122243A0 (en)	1998-04-05
AU714447B2 (en)	2000-01-06
SK177097A3 (en)	1998-08-05
HU228984B1 (en)	2013-07-29
NO317867B1 (no)	2004-12-27
PL323943A1 (en)	1998-04-27
EP0835263B9 (en)	2002-07-24
CZ297381B6 (cs)	2006-11-15
PT835263E (pt)	2002-04-29
MY147327A (en)	2012-11-30
ATE210152T1 (de)	2001-12-15
PL184947B1 (pl)	2003-01-31
JP3445796B2 (ja)	2003-09-08
JPH11506108A (ja)	1999-06-02
HUP9901455A3 (en)	2000-11-28
SK284087B6 (sk)	2004-09-08
CA2222524A1 (en)	1997-01-16
NZ313147A (en)	1999-11-29
EP0835263B1 (en)	2001-12-05
AU6515096A (en)	1997-01-30
CZ419697A3 (cs)	1998-05-13
DE69617687D1 (de)	2002-01-17
CN1156492C (zh)	2004-07-07
BR9609335B1 (pt)	2009-08-11
TR199701718T1 (xx)	1998-05-21
DE69617687T2 (de)	2002-08-22
NO976064L (no)	1998-02-16
BR9609335A (pt)	1999-05-25
HUP9901455A2 (hu)	1999-09-28
CA2222524C (en)	2010-01-26
KR100454664B1 (ko)	2005-09-12

Publication	Publication Date	Title
ATE210152T1 (de)	2001-12-15	Somatostatinpeptide
DE69129865D1 (de)	1998-08-27	Osteogene peptide
MX9709962A (es)	1998-03-31	Peptidos de somatostatina.
ATE201696T1 (de)	2001-06-15	Zyklische peptidanaloga von somatostatin
KR840007569A (ko)	1984-12-08	Grf 유사체 펩티드의 제법
ATE146188T1 (de)	1996-12-15	Substituierungsanaloge von magaininpeptiden
IE872983L (en)	1988-05-06	Peptides
ES2051647A1 (es)	1994-06-16	Procedimiento para la preparacion de calcitonina de salmon.
ATE215558T1 (de)	2002-04-15	Biotinderivate
ECSP961798A (es)	1997-11-28	Peptidos de somatostatina
KR890701628A (ko)	1989-12-21	단백질(성) 감미제의 제조
AR247473A1 (es)	1995-01-31	Una composicion que produce una respuesta lactogenica o crecimiento en ganado bovino, excluidas todas sus aplicaciones terapeuticas
WO2003044159A9 (en)	2013-10-31	Zinc finger proteins, polynucleotides encoding same and antibodies thereto
AR004485A1 (es)	1998-12-16	Insulina de cadena sencilla con alta bioactividad

Legal Events

Date	Code	Title	Description
2016-07-11	MK1K	Patent expired